These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3695489)

  • 21. Stimulative effects of estrogens on tumor growth and 5 alpha-steroid production in a mouse Leydig cell tumor line (T 124958-R).
    Noguchi S; Nishizawa Y; Takatsuka D; Sato B; Matsumoto K
    Cancer Res; 1986 Feb; 46(2):573-6. PubMed ID: 3484430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
    Lykkesfeldt AE; Larsen SS; Briand P
    Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple estrogen binding sites in malignant mouse Leydig cells and their role in cell proliferation.
    Sato B; Maeda Y; Nakao M; Noma K; Kishimoto S; Matsumoto K
    Eur J Cancer Clin Oncol; 1985 Feb; 21(2):199-205. PubMed ID: 3987757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP; Jordan VC
    Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of 3 H-estradiol in transplanted interstitial cell tumors in mice.
    Bollengier WE; Eisenfeld AJ; Gardner WU
    J Natl Cancer Inst; 1973 Jan; 50(1):195-200. PubMed ID: 4692860
    [No Abstract]   [Full Text] [Related]  

  • 26. Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells.
    Gierthy JF; Lincoln DW; Roth KE; Bowser SS; Bennett JA; Bradley L; Dickerman HW
    J Cell Biochem; 1991 Feb; 45(2):177-87. PubMed ID: 2055945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
    van Agthoven T; van Agthoven TL; Dekker A; Foekens JA; Dorssers LC
    Mol Endocrinol; 1994 Nov; 8(11):1474-83. PubMed ID: 7533260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
    J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK; Hobbs K; Clark GM
    Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.
    Jordan VC; Gottardis MM; Robinson SP; Friedl A
    J Steroid Biochem; 1989; 34(1-6):169-76. PubMed ID: 2626014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apparent lack of immunogenicity of estrogen-induced testicular Leydig cell tumors in BALB/c mice.
    Huseby RA; Page RH
    Cancer Res; 1982 Nov; 42(11):4332-8. PubMed ID: 6751521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of androgen on proliferation of estrogen-responsive transformed mouse Leydig cells in serum-free culture.
    Nishizawa Y; Sato B; Nishii K; Kishimoto S; Matsumoto K
    Cancer Res; 1989 Mar; 49(6):1377-82. PubMed ID: 2924294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estradiol receptor levels in spontaneous Leydig cell tumors of Fischer rats.
    Dubé JY; Tremblay RR; Frenette G; Lesage R; Tremblay M
    J Steroid Biochem; 1980 Jun; 13(6):573-6. PubMed ID: 7382497
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation.
    Sirianni R; Chimento A; Malivindi R; Mazzitelli I; Andò S; Pezzi V
    Cancer Res; 2007 Sep; 67(17):8368-77. PubMed ID: 17804753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
    Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
    Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of estrogen receptor-like high affinity components by exposure of cytosols from mouse Leydig cell tumor or male rat liver to chaotropic salts.
    Sato B; Nishizawa Y; Maeda Y; Noma K; Matsumoto K; Yamamura Y
    J Steroid Biochem; 1981 Jun; 14(7):619-24. PubMed ID: 7265965
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.
    Hoffmann J; Bohlmann R; Heinrich N; Hofmeister H; Kroll J; Künzer H; Lichtner RB; Nishino Y; Parczyk K; Sauer G; Gieschen H; Ulbrich HF; Schneider MR
    J Natl Cancer Inst; 2004 Feb; 96(3):210-8. PubMed ID: 14759988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcellular distribution of cyclic adenosine 3',5'-monophosphate-binding protein and estrogen receptors in control pituitaries and estrogen-induced pituitary tumors.
    Piroli G; Weisenberg LS; Grillo C; De Nicola AF
    J Natl Cancer Inst; 1990 Apr; 82(7):596-601. PubMed ID: 1690304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.